Clinical trial NCT02039297: Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)
Official title: Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Critical Illness
Sepsis
Respiratory Failure
Shock
Coma
Bleeding
Trauma
Keywords: AWARE, Checklist, ICU, Outcome, Adults
Lead sponsor: Mayo Clinic
Sponsor class: OTHER
Collaborators: name: Centers for Medicare and Medicaid Services
First posted: 2014-01-17
Enrollment: 7813
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: In this multicenter project, we will introduce AWARE (electronic interface) Using a cloud-based technology . The goal of this project is to improve compliance with best practice through the use of a new acute care interface with built-in tools for error prevention, practice surveillance and reporting (ProCCESs AWARE - Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation).The goal of this project is to develop and test a novel acute care interface with built-in tools for error prevention, practice surveillance, decision support and reporting (ProCCESs AWARE - Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation). In preliminary studies, these novel informatics supports built on an advanced understanding of cognitive and organizational ergonomics, have significantly decreased the cognitive load of bedside providers and reduced medical errors. Using a cloud-based technology, AWARE will be uniformly available on either mobile or fixed computing devices and applied in a standardized manner in medical and surgical ICUs of five geographically diverse acute care hospitals predominantly serving Medicare and Medicaid patients. The impact of ProCCESs AWARE on processes of care and outcomes in study ICUs; expected to enroll more than 10,000 critically ill patients during the study period.


Eligibility criteria: Inclusion Criteria:

For the Primary Objective, all critically ill adult patient admitted to an ICU participating in the study will be eligible.

Exclusion Criteria:

For the Primary Objective, all children younger than 18years of age will be excluded.

Primary outcomes:
measure: Adherence to process of care
timeFrame: Participants will be followed for the duration of ICU stay, an expected average of 3 days
Secondary outcomes:
measure: Patient outcomes
timeFrame: Hospital length of stay - 2 weeks
Other outcomes:
measure: Cost of patient care in ICU and Hospital
timeFrame: Hospital length of stay - 2 weeks
Locations:
city: Scottsdale
country: United States
facility: Mayo Clinic Arizona
state: Arizona
city: Jacksonville
country: United States
facility: Mayo Clinic
state: Florida
city: Lawrence
country: United States
facility: Lawrence Genral Hospital
state: Massachusetts
city: Rochester
country: United States
facility: Mayo Clinic in Rochester
state: Minnesota
city: The Bronx
country: United States
facility: Montefiore Medical Center
state: New York
city: Oklahoma City
country: United States
facility: OU Medical center
state: Oklahoma
Study officials:
affiliation: Mayo Clinic
name: Brian Pickering, MBBCh
role: PRINCIPAL_INVESTIGATOR
affiliation: Mayo Clinic
name: Ognjen Gajic, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Mayo Clinic
name: Vitaly Herasevich, MD PhD
role: PRINCIPAL_INVESTIGATOR
References: